CUSIP: G31659108
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
13,346,928
-
Share change
-
+13,152,185
-
Total reported value
-
$139,614,000
-
Price per share
-
$10.47
-
Number of holders
-
60
-
Value change
-
+$137,586,000
-
Number of buys
-
57
Quarterly Holders Quick Answers
What is CUSIP G31659108?
CUSIP G31659108 identifies ARYD - ADAGIO MED HLDGS INC COM - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G31659108:
Institutional Holders of ADAGIO MED HLDGS INC COM - Stock (ARYD) as of Q1 2021
As of 31 Mar 2021,
ADAGIO MED HLDGS INC COM - Stock (ARYD) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,346,928 shares.
The largest 10 holders included
HealthCor Management, L.P., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., Farallon Capital Management, L.L.C., Affinity Asset Advisors, LLC, Bain Capital Life Sciences Investors, LLC, Alyeska Investment Group, L.P., PURA VIDA INVESTMENTS, LLC, and RTW INVESTMENTS, LP.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.